Targeted prostate cancer treatment cuts risk of side effects, study suggests
Reported byBBC News ↗·Sourced by Goodlede
A 10-year NHS study led by Imperial College London followed nearly 3,500 men who received focal therapy for prostate cancer; after 10 years, only two had died from the disease, with outcomes matching surgery or radiotherapy but with less than half the risk of side effects like incontinence or sexual dysfunction.
Focal therapy is not suitable for men whose cancer is in multiple parts of the prostate or has spread beyond the gland.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at BBC News
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Environment
How Eating Healthier Could Reshape Agriculture
Nautilus · Verified
Animals
Gone for 60 Years, Indian Grey Hornbills Return to Gir — What It Reveals About the Forest
The Better India · Verified
Human Feats
In Pictures: The Boy From a Village With No School Grew Up to Warm Ladakh's Coldest Classrooms
The Better India · Verified